Search results
Takeda profit slumps by half as Japanese drugmaker rebuilds pipeline
KFGO· 6 days agoTOKYO (Reuters) - Japan's Takeda Pharmaceutical said full-year earnings slumped by more than half as...
QRG Capital Management Inc. Sells 34,932 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)
ETF DAILY NEWS· 17 hours agoQRG Capital Management Inc. cut its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 9.8% during the 4th quarter, ...
Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss — Update
Morningstar· 6 days agoBy Kosaku Narioka Takeda Pharmaceutical reported a fourth-quarter loss and forecast a drop in annual net profit due partly to restructuring expenses. The ...
Japan's Takeda Pharma Outlines $900M Overhaul To Boost Growth, As 2023 Profit Fall Over 50%
Benzinga· 5 days agoOn Thursday, Japan’s drugmaker Takeda Pharmaceutical Company Limited TAK announced a restructuring...
Takeda stock down 1% as operating profit declines
Investing.com· 6 days agoTakeda Pharmaceutical (TYO: 4502 ) Company Limited (NYSE: TAK ) has surpassed its management guidance for revenue and core earnings per share (EPS) in...
Takeda nabs option to license Alzheimer’s immunotherapies from AC Immune
BioPharma Dive via Yahoo Finance· 2 days agoThe deal — worth $100 million up front and potentially billions more later on — gives Takeda an...
Scilex reaches settlement in patent lawsuit over Gloperba By Investing.com
Investing.com· 8 hours agoFederal Trade Commission and Department of Justice regarding its Settlement Agreement with Takeda ...
Takeda Pharmaceutical Co ADR (TAK) Shares Down Despite Recent Market Volatility – News Heater
NewsHeater· 7 days agoThe stock price of Takeda Pharmaceutical Co ADR (NYSE: TAK) has plunged by -0.60 when compared to previous closing price of 13.36, but the company has seen ...
...s-Focused AC Immune Stock Trading Higher On Monday? - AC Immune (NASDAQ:ACIU), Takeda ...
Benzinga· 1 day agoMonday, Takeda Pharmaceutical Company Limited TAK and AC Immune SA ACIU announced an exclusive, worldwide option and license agreement for AC Immune’s active ...
Takeda Pharmaceuticals earnings: profits, EPS down over 50% in Q4 financial results | Invezz
Invezz· 6 days agoThe company described it in a press release as “a year of significant loss-of-exclusivity impact”, a...